Navigation Links
Inflammatory molecules released by pollen trigger allergies

How do pollen particles provoke allergic reactions? A new study in the February 21 issue of The Journal of Experimental Medicine puts some of the blame on bioactive molecules that are released from pollen. These molecules bind to immune cells and cause them to launch a typical allergy-promoting immune response. Pollen from plants exposed to air pollutants produce more of these allergy-provoking compounds than do pollen from unpolluted areas, possibly explaining why allergies are more prevalent in places with high levels of car exhaust emissions.

Traidl-Hoffmann and colleagues showed that extracts from birch pollen and other common allergens block the production of a soluble protein by immune cells that normally inhibits allergic reactions. They went on to identify the compound in the pollen extracts that caused the inhibitory response and showed that it was similar to certain pro-inflammatory molecules produced in the body in response to injury or infection. The authors now plan to assess whether cells from allergy-prone people are more sensitive to the effects of the pollen-derived compound than those from non-allergic individuals. A better understanding of these molecules and how they work may eventually lead to new approaches to treating allergies.


'"/>

Source:Journal of Experimental Medicine


Page: 1

Related biology news :

1. FDA Announces Series of Changes to the Class of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
2. Medical molecules designed to respond to visible light that can penetrate tissue
3. DNA constraints control structure of attached macromolecules
4. Scientists discover that three molecules may be developed into new Alzheimers drugs
5. Physical and functional interaction of key cell growth molecules linked to cancer
6. Scientists discover new way to look at how molecules twist and turn on water
7. Scientists learn to predict protein-stabilizing ability of small molecules
8. Tiny RNA molecules fine-tune the brains synapses
9. Convergent evolution of molecules in electric fish
10. Micro-boxes of water used to study single molecules
11. Researchers unveil strategy for creating actively-programmed anti-cancer molecules
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/15/2016)... Canada and BADEN-BADEN, Germany , ... a leading global financial services provider, today announced an agreement ... passive behavioural biometrics, to join forces. The partnership will enable ... mitigation strategies in compliance with local data protection regulation. ... In order ...
(Date:12/15/2016)... , Dec. 15, 2016  There is much ... doors or starting the engine. Continental will demonstrate the ... Las Vegas . Through the combination of ... and Entry) and biometric elements, the international technology company ... vehicle personalization and authentication. "The integration of ...
(Date:12/8/2016)...  Singulex, Inc., the leader in Next Generation Immunodiagnostics ... license and supply agreement with Thermo Fisher Scientific, the ... access to Thermo Scientific BRAHMS PCT (Procalcitonin), a biomarker ... to diagnose systemic bacterial infection and sepsis and in ... in assessing the risk of critically ill patients for ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... Aratana Therapeutics, Inc. (NASDAQ: PETX ... development and commercialization of innovative biopharmaceutical products for companion ... North America 2016. ... on the FDA approval of three innovative therapeutics in ... (capromorelin oral solution) and NOCITA ® (bupivacaine liposome ...
(Date:1/20/2017)... -- http://www.Financialbuzz.com - According to ... of death worldwide. There were 8.2 million cancer related ... deaths increased gradually over time, the death rates have ... cancers continues to drive demand of biological therapies for ... Insights, Inc. cancer biological therapy market size was USD 61.3 ...
(Date:1/19/2017)... 19, 2017 /PRNewswire -- WuXi AppTec, a leading ... and technology platform, today announced that it has ... preclinical drug discovery contract research organization (CRO). After ... wholly-owned subsidiary of WuXi, and will continue to ... greater services. The acquisition will further strengthen WuXi,s ...
(Date:1/19/2017)... , Jan. 19, 2017  ArmaGen, Inc., ... Schmidt , Ph.D., as chief executive officer, as ... directors. Dr. Schmidt brings to ArmaGen more than 17 ... research and development of biotherapeutics and pharmaceuticals. ... with the diverse experience and skillset necessary to ...
Breaking Biology Technology: